The global sterile filtration market is expected to reach USD 7.46 Billion by 2020 from USD 4.00 Billion in 2015, at a CAGR of 12.4% from 2015 to 2020.
Increase in R&D spending, growth in the biopharmaceutical industry, growing demand for biopharmaceutical molecules, rising incidence of diabetes & kidney failure, and increasing purity requirement in end-users, are the primary growth drivers for this market during the forecast period (2015–2020). However, stringent government regulations for validation of filtration process may hinder the growth of this market.
The global sterile filtration market is segmented on the basis of products, applications, membrane pore size, and end-user.
Download the PDF Brochure@ http://bit.ly/2StBjfI
On the basis of product, the market is segmented into membrane filters, cartridges & capsules, syringe filters, bottle-top vacuum filters, filter funnels & holders, and filtration accessories. Of these, the membrane filters product segment accounted for the largest share of the global sterile filtration market in 2015, large share of this segment can primarily be attributed to the increasing use of membrane filters for various filtration applications and higher frequency of purchase of these filters as compared to cartridges & capsules, syringe filters, and bottle-top vacuum filters.
On the basis of end-user, the market is segmented into pharmaceutical & biotechnology companies, academic institutes & research laboratories, food & beverage industry, and water filtration companies. Of these, the pharmaceutical & biotechnology end-user segment accounted for the largest share of the global sterile filtration market in 2015, large share of this segment is due to the utilization of sterile filtration techniques for meeting filtration and separation requirements from R&D activities to early-stage product development to full-scale manufacturing in the pharmaceutical & biotechnology companies.
By membrane pore size, the market is divided into 0.22, 0.45 & 0.1 microns. Of these, the 0.22 microns accounted for the largest growing segment in the global sterile filtration market by 2020. On the basis of applications, the sterile filtration market is categorized into bioprocesses, fill-finish process, utilities filtration, pre-filtration, and virus filtration.
The geographic segments included in this report are North America, Europe, Asia, and Rest of the World (RoW). Geographic analysis reveals that North America accounted for the largest share of the global sterile filtration market in 2015. Growth in this market can be attributed to the growth of biopharmaceutical industry and increase in R&D spending.
You Can Also Ask for the Customized Information As Per Your Requirements@
http://bit.ly/2CPgmGK
Pall Corporation (U.S.) held the second position in the sterile filtration market in 2014. The company has strong geographical presence and robust product portfolio for several sterile filtration applications such as cell culture growth media, buffer filtration, recombinant protein, virus filtration, and other bioprocesses applications. The company adopted merger & acquisition as its key business strategies to uphold its leading position in the global sterile filtration market. For instance, in December 2013, Pall Corporation acquired ATMI LifeSciences business for ~USD 185 million. ATMI LifeSciences is a technology leader in the field of single-use bioprocess systems and consumables for the pharmaceutical and biopharmaceutical industries.
The major players in this market include Merck & Co., Inc. (U.S.), General Electric Company (U.S.), Pall Corporation (U.S.), Parker Hannifin Corporation (U.S.), Sartorius Stedim Biotech Group (France), Sigma Aldrich Corporation (U.S.), 3M (U.S.), Porvair Filtration Group (U.K.), Starlabs Scientific (U.S.), and Sterlitech Corporation (U.S.).
The global sterile filtration market is highly evolved, with multiple product segments. An analysis of the market developments between 2013 and 2015 revealed that new product launches was the most important growth strategy employed by market leaders in this period. This strategy was adopted by all the players in this market.
The other important growth strategy adopted by players in this market is expansion, collaborations & partnerships. This strategy was adopted by the players market to enhance their product portfolio. These strategies were adopted by major the players in this market such as General Electric Company (U.S.), Parker Hannifin Corporation (U.S.), Sartorius Stedim Biotech Group (France), and Porvair Filtration Group (U.K.) between 2013 and 2015.
